Our results demonstrated that Herceptin promoted NK cell proliferation, cytotoxicity, and migration by occupying CD16 to enhance the antitumor effects of NK cells on HER2+ breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.